Rocket Pharmaceuticals, Inc. (RCKT) Revenue by Segment & Business Profile

Genetic therapies for rare and devastating diseases was 100.0% of Rocket Pharmaceuticals, Inc.'s revenue, according to EquiReason's reading of its SEC filings.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

RCKTRocket Pharmaceuticals, Inc.Follow RCKT — free

Biotechnology · Healthcare

—

Price chart with a free account

Market cap: 251.4M
P/E TTM: —
Dividend yield: —
52-week: —
Next earnings: 5 Nov, in 12 days

What the company does

Rocket Pharmaceuticals, Inc. is a biotechnology company in the healthcare sector. Trailing twelve-month revenue: $0 as of 2026-06-30.

Roles we read

from the filings, not the sector label

Clinical-stage developer

Rocket Pharmaceuticals, Inc. — questions

What does Rocket Pharmaceuticals, Inc. do?: Rocket Pharmaceuticals, Inc. is a biotechnology company in the healthcare sector. Trailing twelve-month revenue: $0 as of 2026-06-30.
How does Rocket Pharmaceuticals, Inc. make money?: By the lines it reports in its SEC filings: Genetic therapies for rare and devastating diseases 100.0% of revenue.

Every figure on this page comes from Rocket Pharmaceuticals, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.

Important information. Figures on this page are taken from filings submitted to the U.S. Securities and Exchange Commission (SEC) and processed automatically by EquiReason. They may contain errors, omissions or delays, and EquiReason makes no representation or warranty as to their accuracy, completeness or timeliness. Always verify figures against the original filing on SEC EDGAR before relying on them.

This page is provided for general information and educational purposes only. It does not constitute investment, financial, legal or tax advice, and it is not a recommendation or an offer to buy, sell or hold any security. It does not take into account your objectives, financial situation or needs. Past performance does not guarantee future results; any reliance on this information is at your own risk. See our Disclaimer and Risk Disclosure.